ngered by a controversial Allergan (AGN) patent maneuver, a handful of lawmakers introduced a bill that would prohibit tribal sovereign immunity from being used to block certain types of patent challenges.

The move comes six months after Allergan transferred six patents for its best-selling Restasis eye treatment to the St. Regis Mohawk tribe, which has sovereign immunity and has attempted to use its status to block patent challenges filed by several generic drug makers.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.